TLS Advisors LLC 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-05-27 11:59 am Sale |
2020-03-11 | 13D | Ovid Therapeutics Inc. OVID |
TLS Advisors LLC | 2,489,415 4.550% |
-477,450 (-16.09%) |
Filing |